Tilray

Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 13 countries spanning five continents. Tilray supports clinical and observational studies in Canada, the United States, the European Union, and Australia, examining the efficacy of medical cannabis as a treatment for pediatric epilepsy, essential tremor, post-traumatic stress disorder, and alcohol use disorder, and to address the side effects of cancer chemotherapy.